Business Description
Longboard Pharmaceuticals Inc
NAICS : 541714
SIC : 2834
ISIN : US54300N1037
Description
Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. The company is working to improve a portfolio of centrally acting product candidates designed to be selective for specific G protein-coupled receptors (GPCRs). The company is evaluating LP352, an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with negligible observed impact on 5-HT2B and 5-HT2A receptor subtypes, in development for the potential treatment of seizures associated with a broad range of developmental and epileptic encephalopathies.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 102.1 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -43.2 | |||||
| 3-Year EPS without NRI Growth Rate | -41.1 | |||||
| 3-Year FCF Growth Rate | -122.6 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.37 | |||||
| 9-Day RSI | 58.1 | |||||
| 14-Day RSI | 56.41 | |||||
| 6-1 Month Momentum % | 228.26 | |||||
| 12-1 Month Momentum % | 119.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.14 | |||||
| Quick Ratio | 5.14 | |||||
| Cash Ratio | 4.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.2 | |||||
| Shareholder Yield % | -3.83 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -95.59 | |||||
| ROA % | -83.45 | |||||
| ROIC % | -1931.1 | |||||
| ROC (Joel Greenblatt) % | -9425.27 | |||||
| ROCE % | -99.34 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 12.81 | |||||
| Price-to-Tangible-Book | 12.8 | |||||
| EV-to-EBIT | -13.8 | |||||
| EV-to-EBITDA | -13.8 | |||||
| EV-to-Forward-EBITDA | -12.9 | |||||
| EV-to-FCF | -15.39 | |||||
| Price-to-Net-Current-Asset-Value | 12.95 | |||||
| Price-to-Net-Cash | 13.53 | |||||
| Earnings Yield (Greenblatt) % | -7.25 | |||||
| FCF Yield % | -6.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LBPH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Longboard Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.381 | ||
| Beta | 1.55 | ||
| Volatility % | 264.19 | ||
| 14-Day RSI | 56.41 | ||
| 14-Day ATR ($) | 1.509922 | ||
| 20-Day SMA ($) | 19.50025 | ||
| 12-1 Month Momentum % | 119.64 | ||
| 52-Week Range ($) | 3.6 - 28.15 | ||
| Shares Outstanding (Mil) | 38.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Longboard Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Longboard Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Longboard Pharmaceuticals Inc Frequently Asked Questions
What is Longboard Pharmaceuticals Inc(LBPH)'s stock price today?
The current price of LBPH is $21.38. The 52 week high of LBPH is $28.15 and 52 week low is $3.60.
When is next earnings date of Longboard Pharmaceuticals Inc(LBPH)?
The next earnings date of Longboard Pharmaceuticals Inc(LBPH) is 2024-08-02 Est..
Does Longboard Pharmaceuticals Inc(LBPH) pay dividends? If so, how much?
Longboard Pharmaceuticals Inc(LBPH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers